Clinical utility and impact of the use of the chromogenic vs one‐stage factor activity assays in haemophilia A and B

Treatment of haemophilia A/B patients comprises factor VIII (FVIII) or factor IX (FIX) concentrate replacement therapy, respectively. FVIII and FIX activity levels can be measured in clinical laboratories using one‐stage activated partial thromboplastin time (aPTT)‐based clotting or two‐stage chromo...

Descripción completa

Detalles Bibliográficos
Autores principales: Marlar, Richard A., Strandberg, Karin, Shima, Midori, Adcock, Dorothy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916414/
https://www.ncbi.nlm.nih.gov/pubmed/31606899
http://dx.doi.org/10.1111/ejh.13339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916414/
https://www.ncbi.nlm.nih.gov/pubmed/31606899
http://dx.doi.org/10.1111/ejh.13339

Ejemplares similares